Two marketed drugs for adults with Type 2 diabetes have now been approved by the US Food and Drug Administration for children 10 years and older in order to help them improve control over abnormally high levels of glucose in their blood. The drugs, Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride), are both approved oral therapies intended to supplement diet and exercise. Both medicines contain empagliflozin, a sodium-glucose co-transporter which works by increasing the excretion of glucose in the urine.
